Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus.
Asena Gökçay CanpolatRıfat EmralÇağlar KeskinŞule CanlarMustafa ŞahinDemet ÇorapçioğluPublished in: Biomarkers in medicine (2019)
Aim: We assessed the association of monocyte count to high-density lipoprotein cholesterol ratio (MHR) with diabetic peripheral neuropathy (DPN) and its role as a marker for identification of high-risk patients for DPN. Methods: A total of 180 patients with Type II diabetes mellitus (T2DM) were enrolled in the study. MHR, erythrocyte sedimentation rate and serum CRP along with other tests for T2DM and DPN were measured. Results: Duration of T2DM (p = 0.013), insulin use (p = 0.006) and serum CRP levels (p = 0.008) were significantly higher in patients with DPN. MHR was similar between groups (p = 0.447). Duration of diabetes (OR: 1.048; p = 0.038) and the serum CRP levels (OR: 1.073; p = 0.026) were found as independent predictors for the presence of DPN, however, MHR was not. Conclusion: Higher MHR indicates an enhanced inflammation and oxidative stress which was not found to be associated with the presence of DPN.
Keyphrases
- glycemic control
- type diabetes
- oxidative stress
- end stage renal disease
- dendritic cells
- endothelial cells
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- weight loss
- dna damage
- peritoneal dialysis
- ischemia reperfusion injury
- adipose tissue
- metabolic syndrome
- immune response
- skeletal muscle
- wound healing
- diabetic rats
- endoplasmic reticulum stress